Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VANISH-2: Polidocanol Microfoam for Varicose Veins
NCT01231373Phase 3Completed
- Sponsor
- Boston Scientific Corporation
- Start
- Nov 2010
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 10XB101 in Varicose Veins, sponsored by Boston Scientific Corporation. Started Nov 2010; status: completed.
02
Drugs
10XB101
03
Conditions
Varicose Veins
Beyond the preview
Go deeper on NCT01231373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01231373.